Medtronic is the global leader in medical technology – alleviating pain, restoring health, and extending life for millions of people around the world. Every four seconds, somewhere in the world, another life is improved by a Medtronic product or therapy. In the UK Medtronic has been based in Watford for over 35 years. Neuromodulation offers innovative therapies for chronic pain, movement disorders, spasticity, overactive bladder and urinary retention and gastroparesis. Medtronic developed and leads the field of neuromodulation, the targeted and regulated delivery of electrical pulses and pharmaceuticals to specific sites in the nervous system.
Cyberonics, Inc. is a medical technology company with core expertise in neuromodulation. The company developed and markets the VNS Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses an implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide. Since the first clinical experience in 1988, more than 65,000 patients worldwide have been treated with VNS Therapy.
St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient. Headquartered in St. Paul, Minn., St. Jude Medical employs more than 16,000 people worldwide and has four major focus areas that include: cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation.
The St. Jude Medical product portfolio includes implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, pacemakers, electrophysiology catheters, mapping and visualization systems, products for structural heart and vascular diseases, PCI optimization systems, spinal cord stimulation and deep brain stimulation devices.
Boston Scientific Neuromodulation is an innovation leader in implantable DBS technology.
The Vercise DBS System is the first and only DBS system commercially available to incorporate multiple independent current control, which is designed to selectively stimulate targeted areas in the brain. This system is an innovative technology that is designed to provide physicians a fine level control of stimulation.
Through our investments in technology, clinical science, and world-class service, Boston Scientific Neuromodulation is committed to Making life smoother™ for physicians and patients.
Renishaw is a global precision engineering company with core skills in measurement, motion control, spectroscopy and precision machining. We develop innovative products that significantly advance our customers’ operational performance – from improving manufacturing efficiencies and raising product quality, to maximising research capabilities and improving the efficacy of medical procedures. In all of these areas we aim to be a long-term partner, offering superior products that meet our customers’ needs both today and into the future, backed up by responsive, expert technical and commercial support.